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Abstract
Background: (−)-Balanol is an ATP-mimicking inhibitor that non-selectively targets protein kinase C (PKC) isozymes
and cAMP-dependent protein kinase (PKA). While PKA constantly shows tumor promoting activities, PKC isozymes
can ambiguously be tumor promoters or suppressors. In particular, PKCε is frequently implicated in tumorigenesis
and a potential target for anticancer drugs. We recently reported that the C5(S)-fluorinated balanol analogue
(balanoid 1c) had improved binding affinity and selectivity for PKCε but not to the other novel PKC isozymes,
which share a highly similar ATP site. The underlying basis for this fluorine-based selectivity is not entirely
comprehended and needs to be investigated further for the development of ATP mimic inhibitors specific for PKCε.
Results: Using molecular dynamics (MD) simulations assisted by homology modelling and sequence analysis, we
have studied the fluorine-based selectivity in the highly similar ATP sites of novel PKC (nPKC) isozymes. The study
suggests that every nPKC isozyme has different dynamics behaviour in both apo and 1c-bound forms. Interestingly,
the apo form of PKCε, where 1c binds strongly, shows the highest degree of flexibility which dramatically decreases
after binding 1c.
Conclusions: For the first time to the best of our knowledge, we found that the origin of 1c selectivity for PKCε
comes from the unique dynamics feature of each PKC isozyme. Fluorine conformational control in 1c can synergize
with and lock down the dynamics of PKCε, which optimize binding interactions with the ATP site residues of the
enzyme, particularly the invariant Lys437. This finding has implications for further rational design of balanol-based
PKCε inhibitors for cancer drug development.
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Background
(−)-Balanol (referred to as balanol) is an ATP-mimicking
inhibitor [1] from a fungus Verticillium balanoids [2].
Its structure consists of three moieties, the benzamide
(ring A), azepane (ring B), and benzophenone moieties
(ring C and D). These moieties completely fill the flex-
ible ATP site (Fig. 1a) [2]. The benzamide and azepane
moieties occupy the adenine and ribose subsites, re-
spectively, whereas the benzophenone moiety resides in
the triphosphate subsites. In balanol structure, the aze-
pane ring is in a central position [3] that connects the
benzamide and benzophenone moieties. Amide and ester
linkages respectively join the benzamide and benzophe-
none moieties to the azepane.
Balanol is a non-selective inhibitor for cAMP-dependent
protein kinase A (PKA) and protein kinase C (PKC) iso-
zymes that target their ATP sites [4]. While PKA is known
to promote tumor [5], most PKC isozymes show am-
biguous roles in cancer, i.e. they can act as tumor pro-
moters or suppressors, depending on the context [6].
For instance, PKCβI suppresses breast cancer, whereas
PKCα, PKCβII, and PKCδ promote the cancer [6]. In
contrast, PKCβI and PKCδ respectively are promoter
and suppressor in prostate cancer. In particular, PKCε
is consistent oncogene protein and potentially targeted
for anti-cancer drugs [6]. Thus, improving balanol se-
lectivity to PKCε is essential for development of anti-
cancer inhibitor. However, development of isozyme-
specific inhibitors are elusive due to the highly homolo-
gous ATP sites of PKC isozymes, and protein kinases in
general [7].
Extensive structure and activity relationship (SAR)
studies [8–12] have been carried on balanol to improve
its selectivity to certain PKC isozyme, with PKA used as
a reference in some studies [9, 10, 12]. These SAR stud-
ies investigated chemical modifications on the benza-
mide [8], azepane [9], and benzophenone moieties [10–
12] (Fig. 1a). Modifications on the benzamide moiety
showed that the phenolic C5′OH group is critical for
PKC inhibition [8], whereas derivatizations on the ben-
zophenone moiety revealed the importance of the acidic
functional group [10, 11]. In some SAR studies [8, 9], a
five-membered pyrrolidine ring replaced the azepane
ring but did not substantially improve the selectivity of
balanol. The studies showed that the azepane ring can
compromise various derivatization, but selectivity is still
a challenge [10].
Fluorine is a unique element which has been widely
employed in drug development [13, 14]. It can substitute
hydrogen in an organic molecule without considerably
increasing molecular size due to its small atomic size,
1.47 Å which is closer to 1.20 Å for hydrogen. Its highly
electronegative character (Pauling electronegativity of
4.00) causes fluorine forming an extremely polarized C–F
Fig. 1 Structures of a (−)-balanol and b its C5(S)-fluorinated analogue (1c) with c experimental binding affinity to novel PKC isozymes. Each structure
consists of three moieties which reside three different subsites based on structural superimposition of balanol and ATP
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bond. Such bond has a significant ionic character and cre-
ates a low-energy σ* antibonding orbital which can receive
electron density from lone pairs or σ-bonds. These unique
characters make the C–F bond conveying conformational
effect through dipole–dipole interactions, charge–dipole
interactions, and hyperconjugation that can drive molecu-
lar shape [15]. Appropriate fluorination can yield fruitful
effects on conformation, intrinsic potency, pKa, metabolic
pathways, membrane permeability, and pharmacokinetic
properties [13]. Hence, fluorination may bestow a protein
kinase selectivity to balanol.
In a recent study [3], for the first time, we carried out
stereospecific single and multiple fluorinations on the aze-
pane moiety of balanol. The effect of azepane fluorination
on protein selectivity was evaluated by binding affinity
measurement of balanol and the fluorinated balanol ana-
logues (altogether referred as balanoids) to novel PKC
(nPKC) isozymes and PKA [3]. We found that the fluori-
nations on balanol produce various responses to kinases
studied, where the C5(S)-fluorinated analogue or 1c (Fig.
1b) exhibits an improved binding affinity and selectivity to
PKCε (see Fig. 1c) over other nPKC isozymes and PKA.
This stereospecific fluorination offers ligand-enzyme se-
lectivity in highly homologous ATP sites [3].
Understanding the key determinant behind the selectiv-
ity of 1c for PKCε will be beneficial for future develop-
ment of ATP mimic inhibitors based on balanol. This
understanding can be achieved rapidly using computa-
tional approaches, such as molecular dynamics (MD) sim-
ulations. MD simulations offer thorough analysis of the
interaction of 1c with the ATP site residues [16] to un-
cover selectivity of 1c to PKCε. MD also allow to study
the conformational change of ligand and estimate the
binding energy from ensemble conformations. Further-
more, this method gives an opportunity to investigate
induced-fit interactions in ligand binding [17], since pro-
tein kinases possess such plasticity [1]. In our previous
work by exploiting the power of MD [18], we revealed an
interesting factor causing different binding responses of
PKA and PKCε to balanoids. Those different binding re-
sponses are contributed by a structurally equivalent resi-
due in each kinase, Thr184 in PKA and Ala549 in PKCε.
Here, we present a MD study assisted by homology
modelling and sequence analysis of 1c in nPKC isozymes
to unravel selectivity of the balanoid to PKCε. For the first
time to the best of our knowledge, we found that the
unique dynamics feature of each nPKC isozyme lead to 1c
selectivity to PKCε. Although the ATP site residues among
nPKC isozymes are highly similar, the other residues are
relatively low conserved which differently organize resi-
dues in the ATP site and shape the pocket. As a result, the
dynamics responses of nPKC isozymes to 1c are diverged
and yields various binding affinity to the balanoid. Fur-
thermore, fluorine conformational control in 1c exhibits
better synergy with PKCε than the other nPKC isozymes,
resulting in an optimized interaction and a selectivity. Fi-
nally, this study offers beneficial information for the future
rational design of balanol analogues to achieve an im-
proved binding affinity and isozyme selectivity to PKCε.
Methods
Homology modelling
Using a homology modelling approach as described previ-
ously, we built kinase domains of human nPKC isozymes
which bind balanol (for Uniprot ID [19], see Additional file
1: Table S1). In modelling process, we used either single or
multiple templates as listed in Table S1 (Additional file 1).
To examine the structural conservation between both
templates, we carried out structural alignment using Mul-
tiSeq [20] as implemented in Visual Molecular Dynamics
(VMD) 1.9.2 [21]. In the next step, we utilized CLUSTALX
2.1 [22] to align the query to template sequences. More-
over, we manually edited the resulting sequence alignment
to map the ‘open’ conformation [23] of the Gly-rich loop
(GXGXXG) from 1BX6 to PKCε model. Percentage of se-
quence similarity and identity of kinase domains and the
ATP sites were calculated using MatGAT [24].
MODELLER 9.14 [25] was employed to perform hom-
ology modelling. The modelling stage included assigning
balanol from mouse PKA-balanol (PDB ID: 1BX6) to the
generated query structure. This step is to retain the struc-
tural features of the ATP binding site in the resulting
model. Subsequently, Discrete Optimized Protein Energy
(DOPE) score [26], which reflects the quality of the model,
was then used to evaluate the resulting models. Further-
more, we structurally aligned models from multiple runs
of homology modelling and chosen the structure with res-
idues adopting consensus conformations. The selected
model was also assessed using Ramachandran plot as im-
plemented in PROCHECK [27].
Clustering of ATP site interfaces
We utilized the webPIPSA [28] server to cluster ATP site
interfaces of nPKC isozymes based on molecular surface
electrostatic potential (MSEP). Initially, the web-server
computed the MSEPs of the ATP site interfaces calcula-
tion using the University of Houston Brownian Dynamics
(UHBD) program [29]. On the second step, webPIPSA
used the PIPSA algorithm to compare MSEPs and calcu-
late electrostatic distances. Subsequently, the electrostatic
distances were clustered and portrayed as a heat map
using the R statistical software [30].
Molecular dynamics simulation preparation and protocol
Since fully activated human PKC isozymes are phos-
phorylated at specific sites [19], we added phosphate
groups on the kinases studied here at particular sites
(Additional file 1: Table S1) using Discovery Studio
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Visualizer [31]. The initial ligand conformations were
adopted from the natural balanol in 1BX6 (mouse PKA
with bound balanol). Atomic charges of balanoids were
determined using the Austin Model 1 - Bond Charge
Corrections (AM1-BCC) [32] method in AmberTools16
[33]. Parameters for balanoids were derived from the
General Amber Force-fields (GAFF) [34] and determined
using the parmchk program in AmberTools16. We used
ff14SB [35] to assign force-fields for regular amino acid
residues and their side chains, whereas phosaa10 [36]
was utilized for phosphorylated residues.
The preparation step of MD system was performed
using the tleap utility in AmberTools16. We solvated each
complex of each kinase-balanoid complex with explicit
water molecules (TIP3P), where minimum distance be-
tween the protein and box boundary was 10 Å. To achieve
neutral charge and a salt concentration of 0.15 M, which
is the equivalent of physiological salt concentration, we
added sufficient Na+ and Cl− ions to the system.
GPU-accelerated Particle-Mesh Ewald Molecular Dy-
namics (PMEMD), as implemented in Amber16 [33], was
employed throughout simulations where periodic bound-
ary conditions were applied. For each simulation, two con-
secutive steps of energy minimization were carried out
with restraining protein-ligand complex by 25 and 5 kcal.-
mol− 1.Å− 2. For 50 ps, the system temperature was then el-
evated to 300 K under NVT condition and then followed
by equilibration steps. In the next 50 ps NPT simulation,
the system density was equilibrated to 1 g.cm− 1. In the
subsequent NVT simulation, the restraint on protein-lig-
and complex was gradually removed every 50 ps by 1 kcal.-
mol− 1.Å− 2 from 5 kcal.mol− 1.Å− 2 where in the last
equilibrium step of 50 ps, the restraint was eliminated.
Production-phase was simulated under the NPT at
300 K. Particle-mesh Ewald (PME) [37] method was
employed to handle long-range electrostatic interactions.
We set 10 Å cut-off for short-range non-bonded interac-
tions which was also employed by others [38, 39]. To
constrain all bonds involving hydrogen atoms, we imple-
mented a SHAKE algorithm [40]. Meanwhile, we imple-
mented algorithms of Berendsen barostat [41] and
Langevin thermostat [42] to maintain constant pressure
and temperature, respectively. Convergence of simula-
tions were checked by monitoring cosine contents of the
first few principal components using GROMACS [43].
Binding energy calculation
We calculated experimental binding energy values ( Δ
G°exp ) of balanoid 1c to nPKC isozymes and PKA from
dissociation constant (Kd) values (Fig. 1c) [3]. At equilib-
rium and under standard conditions, the binding energy
directly relates to the equilibrium constants and, thus,
can be determined using the following equation (eq. 1):
ΔG°exp ¼ −RTln Kað Þ ¼ RTln Kdð Þ ð1Þ
where ΔG°exp denotes experimental binding energy, re-
spectively Ka and Kd are association and dissociation
constant, R is the universal gas constant, and T is abso-
lute temperature.
Molecular Mechanics Generalized Born Surface Area
(MMGBSA) method [44], which is implemented in
MMPBSA.py [45], was utilized to determine estimated
binding energy values of balanoid 1c to nPKC isozymes
or PKA as well as their per-residue decomposition
(Additional file 1: Note 2). MMGBSA does not incorp-
orate conformational entropy or the free energy of
water molecules in the binding site, although these
components may have a role in protein-ligand interac-
tions. Nevertheless, the MMGBSA method has applied
successfully to rationale experimental data and to im-
prove the results of virtual screening and docking [46].
The MMGBSA binding free energy (ΔG°MMGBSA ) is cal-
culated as follows in eq. 2:
ΔG°MMGBSA ¼ Gcomh ii− Grech ii− Glig
 
i ð2Þ
where 〈Gcom〉i, 〈Grec〉i, and 〈Glig〉i are the average value of
ΔG°MMGBSA for complex, enzyme, and ligand, respect-
ively, over snapshots i extracted from MD trajectories.
Gx can be decomposed as shown in the following eq. 3:
Gx ¼ EMM þ GGBsolv þ GSAsolv ð3Þ
where EMM is the gas phase energy, G
GB
solv is the electro-
static portion of solvation energy computed using Gen-
eralized Born (GB) implicit solvent model, and GSAsolv is
the hydrophobic contribution to the solvation energy.
The hydrophobic contribution was estimated using the
Linear Combination of Pairwise Overlaps (LCPO) [47]
method, whereas EMM was approximated by the molecu-
lar mechanics energy of the molecule. Molecular me-
chanics energy consists of bond (Ebond), angle (Eangle),
torsion energies (Etorsion), van der Waals (EvdW), and
electrostatic interactions (Eel) (eq. 4).
EMM ¼ ΣbondsEbond þ ΣanglesEangle þ ΣtorsionsEtorsion
þΣatomsi≠ j EvdW þ Σatomsi≠ j Eelectrostatic
ð4Þ
Internal energy terms, which include Ebond, Eangle, and
Etorsion, were omitted in this study, since the calculation
was applied on single-trajectory MD simulations [48].
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Charge state validation
We adapted the charge state validation workflow as de-
scribed previously [49]. Briefly, initial charge state of 1c
in each ATP site of nPKC isozyme refers to our previous
work [49], that the amine (N1) on the azepane ring, the
phenolic group (C6′′OH), and the carboxylate (C15′′
O2H) on the benzophenone moiety bear charges. Δ
G°MMGBSA value was computed from each trajectory of
nPKC-bound 1c. Here, we also used PKA-bound 1c tra-
jectory from our previous study [50] for an additional
data point. The resulting ΔG°MMGBSA values were com-
pared with experiment. A detailed description is pre-
sented in (Additional file 1: Note 1, Figures S1 and S2).
MD trajectory analysis
Analyses were performed on trajectories after conver-
gence was reached (Additional file 1: Table S2). To
analyze MD trajectories, we utilized cpptraj program in
AmberTools16 [33]. The analysis consisted of computa-
tion of dihedral angles in the azepane ring, H-bond con-
servation, Solvent-Accessible Surface Area (SASA), and
Root-Mean-Square Fluctuation (RMSF). Principal com-
ponent analysis (PCA) dynamics modelling was per-
formed using ProDy [51] plugin in VMD 1.9.2 [21].
Image and graph generation
Conformational ensembles of balanoid 1c in the ATP
sites of PKC isozymes were visualized in VMD 1.9.2
[21]. The conformations were generated every 1250
frames from the trajectories of the last 100 ns (5000
frames) for analysis purposes. Non-covalent interactions
of kinase-balanoid were depicted using BIOVIA Discov-
ery Studio Visualizer 2016 [31] by referring to H-bond
conservation analysis. Two dimensional (2D) structures
of balanoids were sketched in BIOVIA Draw 2016 [52].
All graphs were produced in RStudio 0.99.892 [53], util-
izing the R statistical software package [30], ggplot2 [54].
For image editing, GNU Image Manipulation Program
(GIMP) 2.8.14 [55] and Inkscape 0.48.5 [56] were used.
Results and discussion
General conformational ensemble of 1c in the ATP sites
of novel PKC isozymes
According to superimposition of the conformational en-
semble of 1c that is bound to nPKC isozymes (Fig. 2),
each moiety of 1c exhibits docking variability in subsites
of the ATP site, where the order is: the benzamide moi-
ety < the azepane ring < the benzophenone moiety.
While the benzamide part of 1c still shows similarity,
the azepane ring docks differently, in particular, the aze-
pane rings of PKCη- (orange) and PKCθ-bound 1c
(cyan), which have Kd above 7 nM (Fig. 1.C). Interest-
ingly, the azepane rings of PKCδ- (green) and PKCε-
bound 1c (magenta) with Kd below 5 nM (Fig. 1.C) are in
a similar docking position. Additionally, the azepane ring
of 1c that is bound to PKCδ and PKCε has similar limited
flexibility in such kinases, whereas the azepane ring is
more fluctuated in PKCη and PKCθ (Fig. 2).
The benzophenone moiety of 1c exhibits the most
position diversity in the triphosphate subsites (Fig. 2). In
PKCε, 1c places its benzophenone moiety deeper inside
the triphosphate subsite than that in nPKC isozymes,
whereas PKCδ-bound 1c shows its ring D swaying to-
ward the subsite floor. In both PKCη and PKCθ, 1c ori-
ents its ring D close to the entrance of the ATP sites
where the benzophenone moiety has more flexible con-
formations in PKCη than PKCθ.
Analysis of sequence alignment and clustering based on
molecular surface electrostatic potential
The various ways of 1c orienting its moieties may be
due to unique environments of the ATP sites of nPKC
isozymes. Therefore, we started to find the unique fea-
ture with sequence analysis (Additional file 1: Figure
S3.A). We found that the ATP site residues, which dir-
ectly contact with balanol, share a high sequence identity
(93–96%) and similarity (100%) (Additional file 1: Table
S3). Only two residues are different which are part of
the adenine subsite (indicated by a green bar, Additional
file 1: Figure S3.A), but they still retain similarities. We
also conducted a cluster analysis on the ATP sites using
molecular surface electrostatic potential (MSEP)-based
methodology (webPIPSA server) [28]. The result also
suggests that nPKC isozymes have very similar MSEP
(Additional file 1: Figure S3.B).
Despite sharing high identity in their ATP sites, the
whole kinase domain residues of nPKC isozymes are
relatively less conserved with 59–76% identity and 77–
90% similarity (Additional file 1: Table S4). As shown in
the sequence alignment (the non-highlighted residues,
Additional file 1: Figure S3.A), non-contact residues that
support the ATP site are varied. These sequence vari-
ation among nPKC isozymes may be implicated in 1c se-
lectivity for PKCε.
Dynamics feature of novel PKC isozymes
As noted above, although those kinases possess highly
identical residues at the ATP binding site, sequence vari-
ation is observed on non-contact residues (Additional
file 1: Figure S3.A). These varied residues may define
structural dynamic features of nPKC isozymes and lead
to unique responses of the kinases to 1c binding. To
evaluate this notion, we carried out separated MD simu-
lations for apo forms of nPKC isozymes here and also
compared them to their related 1c-bound forms (here-
after refers as bound).
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As shown in RMSF plots (Fig. 3 and Additional file 1:
Figure S4) and structural mapping of PCA dynamics
modelling (Additional file 1: Figure S5), nPKC iso-
zymes display different dynamics behavior. In their apo
forms, they show diverse flexibility degree in both con-
tact and non-contact residues of the ATP binding sites
(Additional file 1: Figure S4.A). These results indicate
that the variability on the non-contact residues among
nPKC isozymes determine the dynamics of the contact
residues, which may influence the responses and the
interactions of the kinases to 1c. RMSF plots of nPKC
isozymes in bound forms (Additional file 1: Figure
S4.A) and structural mapping of PCA dynamics model-
ling (Additional file 1: Figure S5) reveal dynamics alter-
ations of the kinases after 1c binding. Similar to the
bound apo forms, the structural dynamics of the bound
forms differ among nPKC isozymes, pointing out that
each kinase responds differently to 1c binding.
We subsequently performed a Wilcoxon rank sum test
to evaluate RMSF differences between the apo and
bound forms of the given kinases. The results suggest
that all nPKC isoforms, except PKCθ, significantly re-
duce their conformational freedom after binding 1c
(Additional file 1: S5). Interestingly, PKCε, which shows
a higher binding affinity to 1c than the other nPKC iso-
forms (Fig. 1), has the most significant difference of con-
formational freedom between its apo and bound form
on the ATP site (p-value = 6.27 × 10− 3; Additional file 1:
Table S5). The 1c binding to PKCε reduces the conform-
ational freedom of the kinase domain by 0.31 Å on aver-
age (Additional file 1: Table S6).
We also conducted analysis of solvent-accessible surface
area (SASA) at the ATP sites of nPKC isoforms in the apo
and bound forms. All nPKC isoforms have slightly differ-
ent SASA in their apo forms in terms of value and fluctu-
ation (Fig. 4; Additional file 1: Table S7). Among nPKC
isoforms, PKCε exhibits the most fluctuating SASA (Fig.
4), which is also reflected by its standard deviation
(2598.62 ± 58.72; Additional file 1: Table S7). These data
suggest that the variation on non-contact residues of the
ATP sites among nPKC isoforms affects dynamics features
and shapes the sites differently. Ultimately, these ATP sites
Fig. 2 Superimposition of conformational ensemble of 1c that is bound to nPKC isozymes (PKCδ, PKCε, PKCη, and PKCθ). On the upper panel,
direction toward reader represents the direction to the entrance of the ATP site
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diversely respond the 1c binding, as shown in SASA
values of nPKC isoforms in bound forms at the ATP
sites (Fig. 4; Additional file 1: Table S7). One interesting
finding here is that the bound form of PKCε, where 1c
is a strong binder, has the lowest and the least
fluctuating SASA values among other nPKC isoforms
(2276.31 ± 38.26 Å2; Additional file 1: Table S7).
These results support our hypothesis that the diversity
on non-contact residues of the ATP sites may engender
a unique dynamics feature for every nPKC isozyme. This
Fig. 3 Root Mean Square Fluctuation (RMSF) plots of novel PKC isozymes in the apo and 1c-bound forms. Root Mean Square Fluctuation (RMSF)
plots of novel PKC isozymes in the apo and 1c-bound forms. Residues of ATP binding sites are indicated by grey-shaded bars
Fig. 4 SASA plots. The plots show SASAs of both the apo and bound forms of nPKC isoforms from the last 100 ns of trajectories
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uniqueness may differently organize the highly identical
residues in the ATP site. As a result, the ATP site of in-
dividual nPKC isozyme may interact differently with 1c.
Interactions of the azepane ring at the ribose subsites
As discussed above, every nPKC isozyme possesses a
unique dynamics feature that may diversely positions
residues of the ATP site. As a consequence, those resi-
dues will interact differently with 1c and explain the
various conformational ensembles of 1c in the ATP sites
of nPKC isozymes (Fig. 2). Therefore, we elucidate inter-
actions made by 1c in every nPKC isozyme, particularly
interactions between the azepane ring and the ribose
subsite. This selection is based on an assumption that
the azepane ring is the central moiety that connects the
benzamide and the benzophenone moieties [3]. Further-
more, the azepane ring is the moiety where the fluorine
substituent is incorporated at the C5(S) position. Any
conformational changes on the azepane ring may inter-
fere the other moieties as monitored in polar charts of
the dihedral angle ω6 (Additional file 1: Figure S6). This
interference may further influence interactions between
the whole 1c molecule and the ATP site.
We start with 1c in PKCε which exhibits the highest
binding. The azepane ring of 1c builds H-bonds with
Asp536 and Asp550 via its N1 amine group (Fig. 5a),
with conservations of 30.8 and 66.0% (Additional file 1:
Table S8), respectively. These interactions help to shape
and rigidify the conformation of the azepane ring (Fig.
2). As a result, the azepane ring less interferes the other
moieties as seen in the trajectory of dihedral angle ω6
(Additional file 1: Figure S6). Furthermore, 1c can
strengthen its interaction with the invariant Lys437 (Fig.
5a; Additional file 1: Note 2), which is considered as the
most contributing residue in the binding of balanoid to
kinases [18]. Balanoid 1c creates a very strong binding
energy with the Lys437 (− 16.83 kcal.mol− 1; Additional
file 1: Figure S7). The synergy between 1c and the dy-
namics feature of PKCε results in interactions that are
free from unfavorable binding energy (Supporting Infor-
mation: Fig. S7), explaining the strong binding affinity of
1c to the kinase [18].
In PKCδ, Asp536 and Asp550 correspond to Asp477
and Asp491. Interactions of N1 with Asp477 and
Asp491 provide H-bond conservation of 46.4 and
99.3% each (Additional file 1: Table S8). These interac-
tions stabilize the binding of 1c to the ATP site of
PKCδ by − 18.01 and − 6.06 kcal.mol− 1 for Asp491 and
Asp477, respectively. Nonetheless, these stabilizations
are violated by an unfavourable binding with Lys475
(0.19 kcal.mol− 1; Additional file 1: Figure S7). In
addition, the uncharged phenolic C6′′OH group
Fig. 5 Interactions of the azepane rings of 1c with the ribose subsite residues of novel PKC isozymes. a and b respectively depict interactions of
1c in PKCε and PKCδ, whereas c and d show interactions of 1c in PKCη and PKCθ, respectively. The invariant Lys and the azepane ring are highlighted
in cyan and orange, respectively. H-bonds are represented by green dashed lines, whereas salt bridges as well as π-cation interactions are depicted by
orange dashed lines. Each conformation is a representative snapshot from the respective simulation
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(Additional file 1: Note 1) causes less options to inter-
act with the invariant Lys378. As a consequence, the
Lys378 only provides a binding contribution to 1c by
− 8.79 kcal.mol− 1 (Additional file 1: Figure S7). Fur-
thermore, the benzamide moiety of 1c obtains weaker
binding contributions in PKCδ than other nPKC iso-
forms (Additional file 1: Figure S7).
1c in PKCε, PKCη, and PKCθ has a same ionization
state. Its azepane ring, however, exhibits different confor-
mations (dihedral angles ω1-ω6; Additional file 1: Figure
S6) and interaction modes with the ribose sites (Fig. 5). In
PKCη, the azepane ring forms attractive charge and
carbonyl-fluorine interactions with Asp483 (Fig. 5). Add-
itionally, it builds a low conserved H-bond with Asp497
through the N1 amine group (Additional file 1: Table S8).
Although these interactions can help to limit flexibility of
the azepane ring in the ribose subsite, 1c acquires rela-
tively a weaker binding contribution from the invariant
Lys384 (− 6.34 kcal.mol− 1; Additional file 1: Figure S7).
Moreover, a repulsive interaction emerges from Glu403
(0.14 kcal.mol− 1) which weakens the binding of 1c to
PKCη.
For the case of 1c binding to PKCθ, residues at the ribose
subsite allow the azepane ring to have conformational flexi-
bility (Fig. 2; Additional file 1: Figure S6). The N1 amine
group in the azepane ring and Asp508 forms a H-bond
with a conservation of 41.9% (Additional file 1: Table S8).
Nevertheless, the amine group is also involved in attractive
interactions with the side chains of Asp465, Asp508, and
Asp522 (Fig. 5) which may contribute to the flexibility of
the azepane ring. Moreover, the fluorine atom interacts
with the backbones of Gly387 and Lys388 (Fig. 5). Such
situation may contribute to the weak interactions of the
benzophenone moiety with the triphosphate residues. For
example, the benzophenone has a relatively weak binding
with the invariant Lys409 and repulsive interactions with
Asp421 and Glu428 (Additional file 1: Figure S7).
The interaction analysis above suggests that the unique
dynamics feature of each novel PKC isozyme differently
organizes its highly identical ATP site residues. As a result,
1c interacts with every nPKC in different modes. While
interactions of 1c to PKCδ, PKCη, and PKCθ generate
repulsive interactions that weaken the binding affinities to
those kinases, this balanoid and PKCε interact in harmony
(Additional file 1: Figure S8). The binding of 1c to PKCε
can optimize interactions to yield a strong affinity, in
particular with invariant Lys437. Additionally, the unique
behavior PKCε provides interactions with 1c that are free
from unfavorable binding energy.
Conclusions
Here, we uncover different binding affinities of a
C5(S)-fluorinated balanol analogue (1c) to the highly
identical ATP sites of novel PKC isozymes. Such disperse
binding affinities are due to the unique dynamics feature
of every isozyme. This unique dynamics feature comes
from the less identical residues beyond the ATP site
which differently organizes the highly identical ATP site
residues. As a result, residues in each ATP site of novel
PKC isozyme interact differently with 1c. The balanoid
1c, that carries fluorine perturbation at the C5(S) pos-
ition in the azepane ring, also responds diversely to each
ATP site which is reflected by its shape, conformational
flexibility, and docking position of its moieties. In the nPKC
isozymes where 1c binds with higher affinities, PKCδ and
PKCε, the azepane ring tend to have limited flexibility. On
the contrary, where 1c binds weaker in PKCη and PKCθ,
more conformational fluctuations occur on the azepane
ring. The way of the azepane ring behaves affecting the
interactions of the other moieties, particularly the benzo-
phenone moiety, with the ATP site residues.
Similar to our previous finding [50], the invariant Lys
residue in the ribose subsite has major contribution on
the binding of 1c. The behavior of the azepane ring may
strengthen or weaken the contribution of the invariant
Lys. Furthermore, it may generate interactions of the
benzophenone moiety with the ATP site residues either
energetically favorable or unfavorable. We found that
only the binding of 1c to PKCε produce interactions
with the ATP residues without causing unfavorable bind-
ing energy contribution, while optimizing binding con-
tribution from the invariant Lys.
Overall, stereocontrolled fluorination in 1c can har-
monically tune with dynamics feature of PKCε but not
the other nPKC isozymes. As a result, 1c only shows co-
operative interaction with the ATP site residues of PKCε,
conferring selectivity for this isozymes. Therefore, the
future design of balanol-based inhibitor need to main-
tain characteristic interactions made by 1c and PKCε,
such as optimal binding with the invariant Lys. This dy-
namic feature finding has implications for the rational
design of balanol-based inhibitors targeting PKCε for
cancer therapy.
Additional file
Additional File 1: This file contains Notes 1 and 2, Figures S1-S8. and
Tables S1-S9. and relevant references. (PDF 3690 kb)
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